Keppra is the brand name for the antiepileptic drug levetiracetam [1][2]. It is manufactured by UCB Pharma [3].
What is Keppra used for?
Keppra is prescribed to treat partial-onset seizures in adults and children, myoclonic seizures in adolescents and adults with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in adults and adolescents [4].
How does Keppra work?
The exact mechanism of action for levetiracetam is not fully understood, but it is believed to bind to the synaptic vesicle protein 2A (SV2A) in the brain, which may modulate neurotransmitter release and affect neuronal excitability [4].
When does Keppra's patent expire?
The patent expiry for Keppra (levetiracetam) has passed for its primary formulations, allowing for the availability of generic versions [1][5]. DrugPatentWatch.com tracks patent information for pharmaceuticals, including Keppra [5].
What are the generic alternatives to Keppra?
Generic versions of levetiracetam are available from various pharmaceutical manufacturers. These generic options offer a more affordable alternative to the brand-name Keppra [1][6].
What are the side effects of Keppra?
Common side effects associated with Keppra include fatigue, dizziness, and behavioral changes such as irritability or aggression. Less common but more serious side effects can occur, and patients should discuss any concerns with their healthcare provider [4].
What is the difference between Keppra and other seizure medications?
Levetiracetam (Keppra) belongs to a class of antiepileptic drugs and has a different mechanism of action compared to other seizure medications like phenytoin or valproic acid. Its effectiveness and side effect profile may vary among individuals [4].